Are Bombed-Out Burberry Group plc, Randgold Resources Limited & Aberdeen Asset Management plc Poised To Bounce Back?

Royston Wild looks at whether Burberry Group plc (LON: BRBY), Randgold Resources Limited (LON: RRS) and Aberdeen Asset Management (LON: ADN) could be set for a stunning rebound.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I am looking at the investment prospects of three battered big-caps.

Burberry Group

Luxury good vendor Burberry (LSE: BRBY) has been one of the major casualties of the FTSE washout of recent months, the stock having conceded 13% since the middle of April alone. This does not come as a huge surprise given that updates during this period have confirmed the sustained sales weakness affecting key Asian markets — just this week the firm announced “the continued challenging environment in Hong Kong” prompted a double-digit-percentage sales decline there during April-June.

The political strife in the key Hong Kong territory is of course a concern, but in the long-term I believe Burberry’s position at fashion’s top table should underpin stunning sales growth across the world, particularly as spending power in developing regions powers higher. Indeed, the bag and coat manufacturer’s latest release showed total underlying revenues leap 8% in the quarter to £407m, with sales in Europe, Middle East, India & Africa (EMEIA) still heading through the roof.

The City expects Burberry to see earnings edge 2% higher for the year concluding March 2016, before recovering sales strength drives the bottom line 11% higher the following year. These projections leave the firm dealing on P/E multiples of 19.9 times and 18.1 times for these years, respectable readings given the terrific brand power of its products and improving digital and global presence.

Randgold Resources

Precious metals play Randgold Resources (LSE: RRS) has also seen its share price duck markedly lower in recent times, and the digger is now dealing 19% lower from levels printed just three months ago. This is no great surprise as the gold price has trekked steadily lower during this period due in large part to a rising US dollar — indeed, a recent bullion price of $1,140 per ounce is hovering just above multi-year lows.

The hard currency has traditionally been a safe-haven during times of macroeconomic and geopolitical turbulence, but this has failed to materialise more recently as expectations of Fed rate hikes — combined with fears over slowing physical demand in Asia — has added to the pressure created by dollar strength. With gold prices languishing, Randgold Resources is expected to suffer a 1% earnings fall in 2015.

Although the firm’s low-cost operations make the miner a superior pick to many of its sector peers, I believe forecasts of a 26% bottom line recovery in 2016 are far wide of the mark. And the stock can hardly be described as cheap, either, with P/E ratios of 25.3 times for this year and 20.1 times for this year and next failing to factor in the risks facing the gold industry.

Aberdeen Asset Management

Conversely, I believe that Aberdeen Asset Management (LSE: ADN) is a stellar selection for bargain hunters thanks to its 17% share-price slump during the past three months. With fears over emerging market growth having moderated more recently — indeed, the company advised in June that “new business inflows have continued to grow” — I expect revenues to stomp steadily higher once more.

Thanks to rejuvenated client activity, the City expects Aberdeen Asset Management to flip from the rare 5% earnings dip posted in the year ending September 2014 to a 2% rise in the current 12-month period, leaving the business changing hands on a super-attractive P/E multiple of 12.3 times — any reading below 15 times is widely considered terrific value. And expectations of an extra 6% rise in 2016 pushes the ratio to an even-better 11.7 times.

On top of this, Aberdeen Asset Management is also anticipated to continue throwing up market-bashing dividend yields — a projected payment of 19.8p per share for this year creates a generous reading of 4.9%. And predictions of a 21.8p reward in 2016 drives the yield to a mouth-watering 5.4%.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any shares mentioned. The Motley Fool UK has recommended Burberry. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.
Investing Articles

£10,000 invested in Tesco shares just a fortnight ago is already worth…

Tesco shares went through a sharp wobble a couple of weeks ago, but here's a look at what's happened to…

Read more »

Young female analyst working at her desk in the office
Investing Articles

9.6% yield! Here’s the dividend forecast for Glencore shares to 2027!

At nearly 10%, Glencore shares have one of the largest dividend yields on the FTSE 100. Here's why they could…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing Articles

£20,000 Stocks and Shares ISA: how long would it take to reach £1 million?

This writer considers how long it would take an investor to reach a seven-figure sum by maxing out their Stocks…

Read more »

British flag, Big Ben, Houses of Parliament and British flag composition
Investing Articles

UK bonds: a once-in-a-decade passive income opportunity?

Gilts are offering some very attractive yields at the moment. But Stephen Wright thinks passive income investors could still do…

Read more »

Frustrated young white male looking disconsolate while sat on his sofa holding a beer
Investing Articles

Down 99%, this stock has been crushed by AI and is now a penny share!

Chegg has gone from being a fast-growth tech stock to a penny share trading for less than $1 in the…

Read more »

Young Asian man drinking coffee at home and looking at his phone
Investing Articles

Could this rapidly growing coffee stock be the next Warren Buffett-style winner?

Discover why a fast-growing US coffee chain could be the next big US growth stock, with similarities to stocks picked…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

2 high-yielding dividend stocks I continue to double down on

Andrew Mackie explores two FTSE 350 high-yielding dividend stocks he's been snapping up in the last few weeks for his…

Read more »

Stack of British pound coins falling on list of share prices
Investing Articles

Why did the AstraZeneca share price just fall, and what should we do?

The AstraZeneca share price just took a hit as President Trump announced a price war against the US pharmaceutical industry.

Read more »